Anti-analgesia of a selective NPFF2 agonist depends on opioid activity

Biochemical and Biophysical Research Communications

Volumn 336, Issue 1, 2005, Pages 197-203

  Roussin, Anne ^a   Serre, Fuschia ^a   Gouardères, Christine ^a   Mazarguil, Honoré ^a   Roumy, Michel ^a   Mollereau, Catherine ^a   Zajac, Jean Marie ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Agonist; Analgesia; Morphine; NPFF receptor

Indexed keywords

ANALGESIC AGENT; CALCIUM ION; CARBACHOL; CYCLIC AMP; DEXTRO ASPARAGINYLPROLYL(N METHYL) ALANYLPHENYLALANYLLEUCYLPHENYLALANYLGLUTAMINYLPROLYLGLUTAMINYLARGINYL PHENYLALANINAMIDE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NEUROPEPTIDE FF; NEUROPEPTIDE RECEPTOR; OPIATE AGONIST; SULFUR 35; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STRAIN; CHO CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEREOCHEMISTRY;

AMINO ACID SEQUENCE; ANALGESICS, OPIOID; ANIMALS; BODY TEMPERATURE; BRAIN; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MICE; MOLECULAR PROBES; RECEPTORS, MUSCARINIC; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION;

EID: 24344441562     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.060     Document Type: Article

References (28)

1. M. Roumy, and J.M. Zajac Neuropeptide FF, pain and analgesia Eur. J. Pharmacol. 345 1998 1 11
2. P. Panula, E. Kalso, M. Nieminen, V.K. Kontinen, A. Brandt, and A. Pertovaara Neuropeptide FF and modulation of pain Brain Res. 848 1999 191 196
3. C. Mollereau, M. Roumy, and J.M. Zajac Opioid-modulating peptides: mechanisms of action Curr. Top. Med. Chem. 5 2005 341 355
4. J.M. Zajac Neuropeptide FF: new molecular insights Trends Pharmacol. Sci. 22 2001 63
5. F.S. Vilim, E. Ziff, Cloning of the neuropeptide NPFF and NPAF precursor from bovine, rat, mouse and human, Abstract for the Society of Neuroscience USA, congress San Diego, November 1995 (1995).
6. S.J. Perry, E.Y. Huang, D. Cronk, J. Bagust, R. Sharma, R.J. Walker, S. Wilson, and J.F. Burke A human gene encoding morphine modulating peptides related to NPFF and FMRFamide FEBS Lett. 409 1997 426 430
7. S. Hinuma, Y. Shintani, S. Fukusumi, N. Iijima, Y. Matsumoto, M. Hosoya, R. Fujii, T. Watanabe, K. Kikuchi, Y. Terao, T. Yano, T. Yamamoto, Y. Kawamata, Y. Habata, M. Asada, C. Kitada, T. Kurokawa, H. Onda, O. Nishimura, M. Tanaka, Y. Ibata, and M. Fujino New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals Nat. Cell Biol. 2 2000 703 708
8. E. Bonnard, O. Burlet-Schiltz, B. Frances, H. Mazarguil, B. Monsarrat, J.M. Zajac, and A. Roussin Identification of neuropeptide FF-related peptides in rodent spinal cords Peptides 22 2001 1085 1092
9. E. Bonnard, O. Burlet-Schiltz, B. Monsarrat, J.-P. Girard, and J.-M. Zajac Identification of proNeuropeptide FFA peptides processed in neuronal and non-neuronal cells and in nervous tissue Eur. J. Biochem. 270 2003 4187 4199
10. M. Roumy, C. Gouarderes, H. Mazarguil, and J.M. Zajac Are neuropeptides FF and SF neurotransmitters in the rat? Biochem. Biophys. Res. Commun. 275 2000 821 824
11. C. Gouarderes, J.A. Tafani, and J.M. Zajac Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord Peptides 19 1998 727 730
12. J.A. Bonini, K.A. Jones, N. Adham, C. Forray, R. Artymyshyn, M.M. Durkin, K.E. Smith, J.A. Tamm, L.W. Boteju, P.P. Lakhlani, R. Raddatz, W.J. Yao, K.L. Ogozalek, N. Boyle, E.V. Kouranova, Y. Quan, P.J. Vaysse, J.M. Wetzel, T.A. Branchek, C. Gerald, and B. Borowsky Identification and characterization of two G protein-coupled receptors for neuropeptide FF J. Biol. Chem. 275 2000 39324 39331
13. N.A. Elshourbagy, R.S. Ames, L.R. Fitzgerald, J.J. Foley, J.K. Chambers, P.G. Szekeres, N.A. Evans, D.B. Schmidt, P.T. Buckley, G.M. Dytko, P.R. Murdock, G. Milligan, D.A. Groarke, K.B. Tan, U. Shabon, P. Nuthulaganti, D.Y. Wang, S. Wilson, D.J. Bergsma, and H.M. Sarau Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor J. Biol. Chem. 275 2000 25965 25971
14. M. Kotani, C. Mollereau, M. Detheux, E. Le Poul, S. Brezillon, J. Vakili, H. Mazarguil, G. Vassart, J.M. Zajac, and M. Parmentier Functional characterization of a human receptor for neuropeptide FF and related peptides Br. J. Pharmacol. 133 2001 138 144
15. C. Mollereau, H. Mazarguil, D. Marcus, I. Quelven, M. Kotani, V. Lannoy, Y. Dumont, R. Quirion, M. Detheux, M. Parmentier, and J.M. Zajac Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists Eur. J. Pharmacol. 451 2002 245 256
16. M. Roumy, M. Garnier, and J.-M. Zajac Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurons Neurosci. Lett. 348 2003 159 162
17. C. Mollereau, H. Mazarguil, J.M. Zajac, and M. Roumy Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells Mol. Pharmacol. 67 2005 965 975
18. C. Gouardères, K. Jhamandas, M. Sutak, and J.-M. Zajac Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues Br. J. Pharmacol. 117 1996 493 501
19. A. Mauborgne, S. Bourgoin, H. Polienor, M. Roumy, G. Simonnet, J.M. Zajac, and F. Cesselin The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord Eur. J. Pharmacol. 430 2001 273 276
20. 125I]EYF as selective radioligands Neuroscience 115 2002 349 361
21. C. Gouardères, A. Puget, and J.M. Zajac Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study Synapse 51 2004 249 269
22. I. Quelven, A. Roussin, and J.M. Zajac Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists Eur. J. Pharmacol. 508 2005 107 114
23. H. Mazarguil, C. Gouarderes, J.A. Tafani, D. Marcus, M. Kotani, C. Mollereau, M. Roumy, and J.M. Zajac Structure-activity relationships of neuropeptide FF: role of C-terminal regions Peptides 22 2001 1471 1478
24. S. Gicquel, H. Mazarguil, M. Allard, G. Simonnet, and J.-M. Zajac Analogs of F8Famide resistant to degradation, with high affinity and in vivo effects Eur. J. Pharmacol. 222 1992 61 67
25. J.C. Sol, A. Roussin, S. Proto, H. Mazarguil, and J.M. Zajac Enzymatic degradation of neuropeptide FF and SQA-neuropeptide FF in the mouse brain Peptides 20 1999 1219 1227
26. C. Desprat, and J.-M. Zajac Hypothermic effects of Neuropeptide FF analogues in mice Pharmacol. Biochem. Behav. 58 1997 559 563
27. B. Frances, H. Lahlou, and J.M. Zajac Cholera and pertussis toxins inhibit differently hypothermic and anti- opioid effects of neuropeptide FF Regul. Pept. 98 2001 13 18
28. P. Oberling, L. Stinus, M. Le Moal, and G. Simonnet Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat Peptides 14 1993 919 924